Completed by | Baseline | End of Therapy | 9 weeks | 20 weeks | 40 weeks | 52 weeks | |
---|---|---|---|---|---|---|---|
ASSESSMENTS | |||||||
Primary Outcomes | |||||||
WSAS | P | X | X | X | X | X | |
Secondary Outcomes | |||||||
PHQ-15 | P | X | X | X | X | X | |
PHQ-9 | P | X | X | X | X | X | |
GAD-7 | P | X | X | X | X | X | |
PPS Questionnaire | P | X | X | X | X | X | |
CGI-patient | P | X | X | X | X | X | |
CSRI | P | X | X | X | X | X | |
EQ-5D-5 L | P | X | X | X | X | X | |
Process Variables | |||||||
Therapy Process Indicators | |||||||
Treatment Attendance and Homework Logb | T | ||||||
Treatment Adherenceb | T | ||||||
Treatment Fidelity | IC | X | |||||
Competence Rating | IC | X | |||||
Satisfaction with Treatmenta | P | X | X | X | |||
CGI-therapist | T | X | |||||
PSYCHLOPSa | P | X | X | X | X | X | |
Mechanisms of Change | |||||||
CBRQ | P | X | X | X | X | X | |
Acceptance Scale | P | X | X | X | X | X | |
Baseline | |||||||
Demographic Variables | P | X | |||||
Clinical Information | P | X | |||||
Preferred Treatment Group | P | X | |||||
Therapist Background Measures | T | X | |||||
Other | |||||||
Concomitant Medications | P | X | X | X | X | X | |
Serious/Adverse Events | P | X | X | X |